Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Navigation
Primary Navigation
Home
Singapore
Asia Pacific
World
Business
Entertainment
Sports
Technology
Secondary Navigation
Singapore
Asia Pacific
World
Search
Search:
Daiichi completes takeover of India's Ranbaxy Labs
By ERIKA KINETZ,Associated Press Writer AP - 2 hours 14 minutes ago
MUMBAI, India - Japan's Daiichi Sankyo Co. has completed its $4 billion acquisition of Ranbaxy Laboratories Ltd., India's largest pharmaceutical company, the companies said Friday.
Daiichi Sankyo Co. agreed to buy a controlling stake in Ranbaxy in June, and the transfer of 63.92 percent of Ranbaxy's equity shares to Daiichi was completed Friday, the companies said.
Daiichi paid 737 rupees ($15.42) per share, according to a Ranbaxy spokesman.
In June, the purchase price represented a premium of 53.5 percent to Ranbaxy's average daily closing price for the prior three months, but the stock has since tanked and closed at 218.4 rupees a share on the Bombay Stock Exchange Friday.
In September, the FDA banned the import of more than 30 of Ranbaxy's generic drugs_ including generic versions of the popular antibiotic Cipro and the cholesterol pill Zocor _ over concerns about manufacturing standards at two of its India plants. Regulators in other countries were quick to follow with probes of their own.
"We are pleased to announce that all the planned transactions of this landmark deal have been successfully completed. We are determined to work with Ranbaxy to realize sustainable growth," Daiichi Sankyo president and chief executive Takashi Shoda said in a statement.
Ranbaxy's CEO Malvinder Mohan Singh said closing of the deal "puts us well on the path to create a hybrid business model that will unlock the strengths of both companies to bring unprecedented value to all stakeholders."
Email Story
IM Story
Printable View
Blog This
Recommend this article
Average (0 votes)
Sign in to recommend this article »
Most Recommended Stories »
Related Articles: Business
EU leaders debate financial reform to-do listAP - 1 hour 5 minutes ago
Myanmar and Bangladesh meet over sea disputeAP - 1 hour 44 minutes ago
Goldman expects China share mkt to improve next yearReuters - 1 hour 44 minutes ago
Dollar mostly lower in EuropeAP - 1 hour 51 minutes ago
Philippines surprises with bank reserve cutReuters - 1 hour 52 minutes ago
Most Popular – Business
Viewed
Among Obama's next challenges: his own security
IMF sees recession in advanced economies in 2009
US doctors tell Liu Xiang he needs surgery
Obama's grandmother, family 'rock', dies on election eve
World stocks plunge on rising recession fears
View Complete List »
Search:
Home
Singapore
Asia Pacific
World
Business
Entertainment
Sports
Technology